Unique Ingredient Identifier Q40Q9N063P is listed as a ingredient substance
| RN | 64-19-7 |
| EC | 200-580-7 |
| NCIT | C61623 |
| RXCUI | 168 |
| PUBCHEM | 176 |
| MF | C2H4O2 |
| INCHI KEY | QTBSBXVTEAMEQO-UHFFFAOYSA-N |
| SMILES | CC(O)=O |
UNII Q40Q9N063P ACETIC ACID is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,INFILTRATION | INJECTION | NA |
| AURICULAR (OTIC) | SUSPENSION | ADJ PH |
| AURICULAR (OTIC) | SUSPENSION, LIQUID | 0.26 % |
| EXTRACORPOREAL | SOLUTION | 0.12 % |
| IM - IV | INJECTION | 0.25 % |
| IM - IV - SC | INJECTION | 0.35 % |
| IM - IV - SC | POWDER, FOR INJECTION SOLUTION | ADJ PH |
| IM - SC | INJECTION | 0.2 % |
| IM - SC | INJECTION, SUSTAINED ACTION | ADJ PH |
| INJECTION | INJECTABLE | ADJ PH |
| INTRA-ARTICULAR | INJECTION | ADJ PH |
| INTRALESIONAL | INJECTION | ADJ PH |
| INTRAMUSCULAR | INJECTION | 0.25 %W/V |
| INTRAMUSCULAR | INJECTION | ADJ PH |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | ADJ PH |
| INTRASYNOVIAL | INJECTION | ADJ PH |
| INTRATRACHEAL | SUSPENSION | ADJ PH |
| INTRAVENOUS | INJECTABLE | 0.1 % |
| INTRAVENOUS | INJECTABLE | ADJ PH |
| INTRAVENOUS | INJECTION | 0.27 % |
| INTRAVENOUS | INJECTION | 0.2 % |
| INTRAVENOUS | INJECTION | 0.2 % |
| INTRAVENOUS | INJECTION | ADJ PH |
| INTRAVENOUS | INJECTION, SOLUTION | 5.4 ug/1mL |
| INTRAVENOUS | INJECTION, SOLUTION | 0.009 % |
| INTRAVENOUS | INJECTION, SOLUTION | ADJ PH |
| INTRAVENOUS | LIQUID, WATER, STERILE, FOR INJECTION | 0.01 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | ADJ PH |
| INTRAVENOUS | SOLUTION | ADJ PH |
| INTRAVENOUS | SOLUTION, INJECTION | 0.4 %W/V |
| IRRIGATION | SOLUTION | ADJ PH |
| IV - SC | INJECTION | 0.2 % |
| IV - SC | LIQUID | 0.2 % |
| IV(INFUSION) | INJECTABLE | 0.14 % |
| IV(INFUSION) | INJECTION | 1 % |
| IV(INFUSION) | INJECTION | ADJ PH |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.27 % |
| IV(INFUSION) | SOLUTION, INJECTION | 0.055 % |
| NASAL | SOLUTION | NA |
| NASAL | SPRAY, METERED | 0.12 %W/V |
| NERVE BLOCK | INJECTION | NA |
| OPHTHALMIC | POWDER, FOR SOLUTION | ADJ PH |
| OPHTHALMIC | SOLUTION | 0.08 % |
| OPHTHALMIC | SOLUTION, DROPS | 0.09 % |
| ORAL | CAPSULE | NA |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 0.36 MG |
| ORAL | CAPSULE, HARD GELATIN | NA |
| ORAL | CONCENTRATE | NA |
| ORAL | SOLUTION | 5 MG/5ML |
| ORAL | SOLUTION, ELIXIR | 1.07 MG/5ML |
| ORAL | SOLUTION, INJECTION | ADJ PH |
| ORAL | SOLUTION, SYRUP | 13.2 MG/5ML |
| ORAL | SYRUP | 0.2 % |
| ORAL | TABLET | 0.002 MG |
| OTIC | SUSPENSION | 0.04 % |
| PARENTERAL | INJECTION | ADJ PH |
| PHOTOPHERESIS | SOLUTION | 0.12 % |
| SOFT TISSUE | INJECTION | ADJ PH |
| SUBCUTANEOUS | INJECTABLE | 0.2 % |
| SUBCUTANEOUS | INJECTION | 0.2 % |
| SUBCUTANEOUS | LIQUID | 0.011 % |
| SUBCUTANEOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.041 % |
| SUBCUTANEOUS | SOLUTION | 0.15 % |
| SUBCUTANEOUS | SOLUTION, INJECTION | 0.11 % |
| SUBMUCOSAL | SOLUTION, INJECTION | ADJ PH |
| TOPICAL | EMULSION, CREAM | NA |
| TOPICAL | SOLUTION | 0.043 % |
| TOPICAL | SPONGE | NA |
| VAGINAL | EMULSION, AEROSOL FOAM | 0.025 % |